TOP STORIES

• REGULATORY Novartis Slapped with 15 Day Biz Suspension over Flawed ADR Reporting
  February 27, 2015

• ACADEMIA Govt-Backed Research Center Looks to License Malaria Vaccine to Mega Pharma
  February 27, 2015

• REGULATORY MHLW OKs 60 New APIs in 2014, Doubling from Year Ago
  February 26, 2015

• BUSINESS Takeda to Acquire Turkish Firm for Up to 14.5 Billion Yen, Earn 13 Branded Generics
  February 25, 2015

• BUSINESS Daiichi Sankyo to Shake Up Japan Organization as Olmetec Patent Expiry Nears
  February 25, 2015

• REGULATORY Shelved Decision on Xarelto Recommendation Doesn’t Mean Disapproval: MHLW
  February 24, 2015

• BUSINESS Sun Pharma Wins Japan Approval for Cravit Generics, Competition with Daiichi Sankyo Might Arise
  February 23, 2015

• REGULATORY Gilead’s Sofosbuvir Could Join NHI Price List in May If OK’ed by PAFSC Panel on March 5
  February 20, 2015

• REGULATORY Chuikyo Approves 26 Products Including Takecab, Zelboraf for Listing
  February 19, 2015

• BUSINESS Edoxaban Can Cover 80% of NOAC-Targeted Patients despite Restricted Use: US Commercial Chief
  February 18, 2015

• REGULATORY Abe Calls for Shrewd Strategies for Pharmas, Industry Consolidation as Necessary
  February 18, 2015

• BUSINESS Nichi-Iko to Exclusively Market Plavix Authorized Generics
  February 17, 2015

• BUSINESS Otsuka Holdings Weighs Staff Realignment as Abilify Patent Expiry Looms
  February 16, 2015

• BUSINESS GSK Eyes Transfer of Oncology Teams to Novartis from March
  February 13, 2015

• BUSINESS Otsuka Pharma Pres. Iwamoto Dies at 54, Holding Firm CEO to Take Over
  February 12, 2015

• BUSINESS Ixazomib, Successor to Velcade, Improved PFS in Interim Analysis of PIII Study: Takeda
  February 12, 2015

• REGULATORY MHLW Pursuing Quick Approval of Japan-OK’ed Drugs in Emerging Markets
  February 10, 2015

• ACADEMIA Keio Researcher to Launch Clinical Trial on Repositioned AD Treatment in April
  February 9, 2015

• ORGANIZATION PhRMA Sets to Make Direct Plea to Finance Minister to Drop Annual Price Cut Plan
  February 6, 2015

• REGULATORY NHI Price System that Would Undermine Wholesalers’ Stable Supply Ability Unacceptable: HIB Director-General
  February 6, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 189
• 190
• 191
• 192
• 193
• 194
• 195
• 196
• 197
• …
• Next ›
• 最終 »